文献速递支持与姑息治疗

癌症治疗功能评估量表:通用版量表的开发与验证

The Functional Assessment of Cancer Therapy Scale: Development and Validation of the General Measure.
PubMed 文献 · J Clin Oncol · 2023-01-01

本研究开发并验证了33条目的一般癌症生活质量量表FACT。五阶段验证过程纳入854例癌症患者和15名肿瘤学专家,从370个初始条目经因子和量表分析最终形成28条目的FACT-G第2版,信效度系数均高,能区分疾病分期、体能状态和住院状态,并对临床变化有反应性。

要点

  • FACT-G为28条目通用癌症生活质量量表,含躯体、功能、社会、情感幸福感及治疗关系满意度分量表。
  • 量表信效度系数均高,能区分疾病分期、体能状态评分和住院状态,并对临床变化有反应性。
  • FACT-G满足肿瘤临床试验对量表简便、简短、可靠、有效和反应性的全部要求。

核心结论

  • FACT-G满足或超过肿瘤临床试验对量表的所有要求,包括给药简便、简短、可靠、有效和对临床变化的反应性。

研究设计与样本

  • 五阶段验证过程纳入854例癌症患者和15名肿瘤学专家,初始370个重叠条目来自对癌症症状患者和肿瘤学专家的开放式访谈。

主要发现

  • 初始370个重叠条目经预设标准缩减为38条目通用版,对545例混合癌症诊断患者进行因子和量表分析后形成28条目FACT-G第2版。
  • FACT-G第2版除总分外,还产生躯体、功能、社会、情感幸福感及治疗关系满意度的分量表评分。
  • 信效度系数均高,量表能区分疾病分期、体能状态评分和住院状态,并对时间变化有反应性。
  • 各分量表对已知在躯体、功能、社会、情感幸福感维度上存在差异的组别表现出不同反应性,支持分别测量生活质量各维度的有效性。

临床怎么用

  • 在肿瘤临床试验中选择FACT-G可增加从患者角度评估生活质量各方面相对权重的能力。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We developed and validated a brief, yet sensitive, 33-item general cancer quality-of-life (QL) measure for evaluating patients receiving cancer treatment, called the Functional Assessment of Cancer Therapy (FACT) scale. METHODS AND RESULTS: The five-phase validation process involved 854 patients with cancer and 15 oncology specialists. The initial pool of 370 overlapping items for breast, lung, and colorectal cancer was generated by open-ended interview with patients experienced with the symptoms of cancer and oncology professionals. Using preselected criteria, items were reduced to a 38-item general version. Factor and scaling analyses of these 38 items on 545 patients with mixed cancer diagnoses resulted in the 28-item FACT-general (FACT-G, version 2). In addition to a total score, this version produces subscale scores for physical, functional, social, and emotional well-being, as well as satisfaction with the treatment relationship. Coefficients of reliability and validity were uniformly high. The scale's ability to discriminate patients on the basis of stage of disease, performance status rating (PSR), and hospitalization status supports its sensitivity. It has also demonstrated sensitivity to change over time. Finally, the validity of measuring separate areas, or dimensions, of QL was supported by the differential responsiveness of subscales when applied to groups known to differ along the dimensions of physical, functional, social, and emotional well-being. CONCLUSION: The FACT-G meets or exceeds all requirements for use in oncology clinical trials, including ease of administration, brevity, reliability, validity, and responsiveness to clinical change. Selecting it for a clinical trial adds the capability to assess the relative weight of various aspects of QL from the patient's perspective.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy Scale: Development and Validation of the General Measure. J Clin Oncol. 2023. PMID: 38056080. doi:10.1200/JCO.22.02775

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。